trimethylsulfoxonium Iodide (CAS NO : 1774-47-6)

Trimethylsulfoxonium Iodide (CAS 1774-47-6) is a pivotal reagent in the North American API intermediates market, primarily serving as the precursor to dimethyloxosulfonium methylide for the Corey-Chaykovsky reaction used in the synthesis of epoxides and cyclopropanes. Trimethyloxosulfonium iodide is increasingly integrated into custom synthesis services within the United States, as domestic CDMOs prioritize high purity fine chemicals with a Pharma/API purity of 99% to ensure stringent regulatory compliance and minimize impurity profiles in downstream therapeutic candidates. Trimethylsulphoxonium iodide has seen a surge in demand from every major US-based bulk chemical supplier due to a strategic shift toward domestic sourcing and supply chain resilience, particularly for specialized applications in the development of semi-finished pharmaceutical formulations and advanced perovskite solar cell modifications. We are an established Trimethylsulfoxonium iodide intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Trimethylsulfoxonium iodide COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities